{"id":30719,"date":"2025-03-24T17:16:05","date_gmt":"2025-03-24T16:16:05","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/info-communication\/news\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/"},"modified":"2025-10-01T13:24:18","modified_gmt":"2025-10-01T12:24:18","slug":"the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/","title":{"rendered":"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study."},"content":{"rendered":"\n<p>The recently published OZAVIE observational study confirms that the combination of ceftazidime and avibactam (CAZ-AVI) is effective, with a clinical success rate ranging from 63.4% to 79% in the treatment of multidrug-resistant Gram-negative (MDR-GNB) infections. These rates increase from 65.6% to 81.7% when studying the clinical response to dual therapy for P. aeruginosa infections. Furthermore, the study highlights the good safety profile of the combination, with 17.4% of adverse events possibly attributable to it, only 6.2% of which were serious. The study also reinforces the role of CAZ-AVI in the therapeutic strategy for MDR-GNB infections, while raising the need to assess its ecological impact in future research.<\/p>\n\n<div class=\"wp-block-columns are-vertically-aligned-bottom is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-bottom is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure data-wp-context=\"{&quot;uploadedSrc&quot;:&quot;https:\\\/\\\/ppr-antibioresistance.inserm.fr\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Capture-decran-2025-03-26-103550.png&quot;,&quot;figureClassNames&quot;:&quot;wp-block-image size-large&quot;,&quot;figureStyles&quot;:null,&quot;imgClassNames&quot;:&quot;wp-image-30216&quot;,&quot;imgStyles&quot;:null,&quot;targetWidth&quot;:795,&quot;targetHeight&quot;:1060,&quot;scaleAttr&quot;:false,&quot;ariaLabel&quot;:&quot;Enlarge image&quot;,&quot;alt&quot;:&quot;&quot;}\" data-wp-interactive=\"core\/image\" class=\"wp-block-image size-large wp-lightbox-container\"><img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"1024\" data-wp-init=\"callbacks.setButtonStyles\" data-wp-on--click=\"actions.showLightbox\" data-wp-on--load=\"callbacks.setButtonStyles\" data-wp-on-window--resize=\"callbacks.setButtonStyles\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\" alt=\"\" class=\"wp-image-30216\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png 768w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-225x300.png 225w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550.png 795w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/><button\n\t\t\tclass=\"lightbox-trigger\"\n\t\t\ttype=\"button\"\n\t\t\taria-haspopup=\"dialog\"\n\t\t\taria-label=\"Enlarge image\"\n\t\t\tdata-wp-init=\"callbacks.initTriggerButton\"\n\t\t\tdata-wp-on--click=\"actions.showLightbox\"\n\t\t\tdata-wp-style--right=\"context.imageButtonRight\"\n\t\t\tdata-wp-style--top=\"context.imageButtonTop\"\n\t\t>\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"12\" height=\"12\" fill=\"none\" viewBox=\"0 0 12 12\">\n\t\t\t\t<path fill=\"#fff\" d=\"M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z\" \/>\n\t\t\t<\/svg>\n\t\t<\/button><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-bottom is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p>Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-25 has-custom-font-size is-style-outline has-small-font-size\"><a class=\"wp-block-button__link has-luminous-vivid-orange-color has-text-color has-link-color wp-element-button\" href=\"https:\/\/pdf.sciencedirectassets.com\/778420\/1-s2.0-S2666991925X00026\/1-s2.0-S2666991925000156\/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEJT%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJIMEYCIQDmII1mOcYJnYFQ8XmF2INCTKGjSUIsnhXOSINeaGcn8QIhAMVEAGH4WM9CX3Zbl72IDxlpE%2B2qhEL7np1J6I6K%2F2fbKrwFCO3%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQBRoMMDU5MDAzNTQ2ODY1IgwWHqrT2NCjsHUswXYqkAWQirMGPwIXr5s4NHCSSuTwnC%2Biyi1ROZ7Qajj8mFDpYuXIz3JueI4ehKJD%2FGwRC68r6I227kZ9FJE0ieOzPSAgixDG%2BB8rlY6gEnARX7GFrHu%2BXQCNqw8G0USLyUjZxHbaFBYvSPGSiCydIE4QgIJviXLu%2FfAzQcyPw%2B0FXn%2Fl8%2FcJAv%2BMd%2FTepBrScu8cSU69zDsKcoQ1CMMw0CxFQa%2Fo0XZZYSmP%2FoGg%2BzD20ZHjueLxx19Ct0QopFb04UBZkfoNFHQsqFEhek0I%2Bx6zWRg86HauXALm4Dm4IuwZGtosROuYs%2BGg3TAEeFMg4xHQjDvF%2FTye6gn4ia0oXCj8reyhIgHPi5epxY0hnUPwJV1tmFBas6c4RFJFIN3xmvmXvB38cR4kKb8MU1LN0kvlNh4lhmN6RbxlKUluq9WvTmOU2%2BCx4%2FAOfWwOZk%2FlF%2FmzAYktHWXuVkxMiSu42G0lz16QW45cUTSWHA31axJjRJ7JalvrGg08sDVBLhKBx2BDoLAzc12ZQw8rkuuwyvNuH%2FQvwW25m%2BUSGBwDdQRJz45vfsmOr6SMUw72QOndX718M5i8CyxDBL68zhuDyW96ibkty15T6%2BBGdIpqz%2F4T81Vc8ISZZfJzLIrVTzwq5MoLFWSNDqDW0fAVqWEuDkLjHLjcFkpMVTIDmV5iUANTr7qbde2k7rMjHDr%2BLXxAvob7fKE96IHQnPgn3dtO%2FYkT8npFniCT3t4wHz3ZVIRf0gaFvxEc6MpgLMiP%2FgpDrFmfHPxS%2FQbkILYYPXEeql%2FghlqqvyE7qXMOXvI5rpAd6pKTzidzQXszFa9JLq4EHvLz0xmwKcySdOGSXdvT8iQCUhiRUT7mQJSB9MtBjDs%2BLuHeYDD%2Fj4W%2FBjqwAejLqjI96FhGHMYybHit8bzKJT22T3A12P44NnZ2D%2FXF1KnwS39ukfuSMocNjpwA3NAPDi13yhnX8FdzVb5AofkQL8QwWm%2FrKOzzPnuuDc7BJzU2DZCbgHRNoqU%2BNru0hE3M0W6dU8t%2F30CpNXsgo4jENmunwXIGH6II1EVyg6nsnBd5OkfnJESSwY2aBK78w5QDBHAaVAtlcN8GP24tT%2F3xDGUOF3UfZHDSLG1QJtyW&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20250324T130150Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Expires=300&amp;X-Amz-Credential=ASIAQ3PHCVTYZCDJ7MMZ%2F20250324%2Fus-east-1%2Fs3%2Faws4_request&amp;X-Amz-Signature=ed4e987f0966cd819494069cbaaaec38ad82ffab8b41881847112f5d23aa4116&amp;hash=253619d269c1901ce5bb0b923b47f72c8cb44a37bc4b836aa67e83a5d54b6633&amp;host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&amp;pii=S2666991925000156&amp;tid=spdf-9501deec-97a7-4bb9-b0f2-5a99a9397671&amp;sid=d849fd98263b08416b0b5e78f22f92b8db54gxrqb&amp;type=client&amp;tsoh=d3d3LnNjaWVuY2VkaXJlY3QuY29t&amp;rh=d3d3LnNjaWVuY2VkaXJlY3QuY29t&amp;ua=1c14575155565702545402&amp;rr=92565c02fdc0d5cd&amp;cc=fr\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Click here<\/strong><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The recently published OZAVIE observational study confirms that the combination of ceftazidime and avibactam (CAZ-AVI) is effective, with a clinical success rate ranging from 63.4% to 79% in the treatment of multidrug-resistant Gram-negative (MDR-GNB) infections. These rates increase from 65.6% to 81.7% when studying the clinical response to dual therapy for P. aeruginosa infections. Furthermore, the study highlights the good safety profile of the combination, with 17.4% of adverse events possibly attributable to it, only 6.2% of which were serious. The study also reinforces the role of CAZ-AVI in the therapeutic strategy for MDR-GNB infections, while raising the need to assess its ecological impact in future research.<\/p>\n","protected":false},"author":275,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[58,56],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study. - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study. - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-24T16:16:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-01T12:24:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\" \/>\n<meta name=\"author\" content=\"supportmlcom\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"supportmlcom\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/\"},\"author\":{\"name\":\"supportmlcom\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\"},\"headline\":\"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study.\",\"datePublished\":\"2025-03-24T16:16:05+00:00\",\"dateModified\":\"2025-10-01T12:24:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/\"},\"wordCount\":132,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\",\"articleSection\":[\"News\",\"Practical info &amp; communications\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/\",\"name\":\"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study. - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\",\"datePublished\":\"2025-03-24T16:16:05+00:00\",\"dateModified\":\"2025-10-01T12:24:18+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\",\"name\":\"supportmlcom\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study. - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/","og_locale":"en_GB","og_type":"article","og_title":"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study. - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2025-03-24T16:16:05+00:00","article_modified_time":"2025-10-01T12:24:18+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png"}],"author":"supportmlcom","twitter_card":"summary_large_image","twitter_misc":{"Written by":"supportmlcom","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/"},"author":{"name":"supportmlcom","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5"},"headline":"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study.","datePublished":"2025-03-24T16:16:05+00:00","dateModified":"2025-10-01T12:24:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/"},"wordCount":132,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png","articleSection":["News","Practical info &amp; communications"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/","name":"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study. - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png","datePublished":"2025-03-24T16:16:05+00:00","dateModified":"2025-10-01T12:24:18+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/the-combination-of-ceftazidime-avibactam-antibiotics-is-effective-and-well-tolerated-according-to-a-french-observational-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"The combination of ceftazidime-avibactam antibiotics is effective and well tolerated, according to a French observational study."}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5","name":"supportmlcom"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-13 18:36:47","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30719"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/275"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=30719"}],"version-history":[{"count":7,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30719\/revisions"}],"predecessor-version":[{"id":30736,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30719\/revisions\/30736"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=30719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=30719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=30719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}